Low double-digit growth in quarterly medical device sales has pushed Abbott to nudge up its earnings projections for the year. The company’s second-quarter report follows FDA green lights earlier this ...

For months, analysts and industry insiders have said the market for medical devices would loosen up after the election, as the results would quell uncertainties about healthcare reform and ...

Trends for medical device manufacturers in 2026 include balancing sustainability costs, flexible automation, AI-driven ...

April 17 (Reuters) - Abbott Laboratories (ABT.N), opens new tab beat Wall Street estimates for quarterly profit on Wednesday on robust sales of its medical devices, but the company's stock fell 3% in ...

In this article, we examine how three leading players — Medtronic MDT, IQVIA IQV and GE HealthCare Technologies GEHC — are ...

Johnson & Johnson raised its full-year sales outlook as it posted gains in both its prescription-drug and medical-device businesses in the latest quarter. The healthcare-products company said Tuesday ...

On Thursday, Baxter International Inc. (NYSE:BAX) reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.

Abbott’s strong medical devices sales boosted the company during the first part of 2024, beating Wall Street expectations and raising its forward-looking financial guidance. The company released its ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Pro-Dex stock analysis: powered surgical instruments maker with heavy customer concentration risk. Read here for more on PDEX ...